Last 12 months
Inside the activity.
2 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2022 Filed Feb 17, 2022 18:59 UTC |
Montecalvo Antonio S.VP Health Policy & Contracting
|
Tax withholdingClass A Common Stock | 718 | $7.78 | $5,586.04 |
DisclosureSEC source: 0001062993-22-004804 · form4.xml · nonDerivative · entry 2 Montecalvo Antonio S. · CIK 0001759261 · VP Health Policy & Contracting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,221 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 18:53 UTC |
Freedman LoriVP and General Counsel
|
Tax withholdingClass A Common Stock | 765 | $7.78 | $5,951.70 |
DisclosureSEC source: 0001062993-22-004798 · form4.xml · nonDerivative · entry 2 Freedman Lori · CIK 0001410291 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,829 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 23:57 UTC |
Grow BrianChief Commercial Officer
|
Tax withholdingClass A Common Stock | 799 | $7.78 | $6,216.22 |
DisclosureSEC source: 0001062993-22-004802 · form4.xml · nonDerivative · entry 2 Grow Brian · CIK 0001759142 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,916 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 23:55 UTC |
Bilbo PatrickChief Operating Officer
|
Tax withholdingClass A Common Stock | 937 | $7.78 | $7,289.86 |
DisclosureSEC source: 0001062993-22-004800 · form4.xml · nonDerivative · entry 2 Bilbo Patrick · CIK 0001759203 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,659 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 23:51 UTC |
Francisco DavidChief Financial Officer
|
Tax withholdingClass A Common Stock | 953 | $7.78 | $7,414.34 |
DisclosureSEC source: 0001062993-22-004796 · form4.xml · nonDerivative · entry 3 Francisco David · CIK 0001846282 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,880 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 23:50 UTC |
Gillheeney Gary S.Director · President and CEO
|
Tax withholdingClass A Common Stock | 4,085 | $7.78 | $31,781.30 |
DisclosureSEC source: 0001062993-22-004794 · form4.xml · nonDerivative · entry 2 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,031 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 19:09 UTC |
Driscoll Michael JosephDirector
|
GrantClass A Common Stock | 20,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004819 · form4.xml · nonDerivative · entry 1 Driscoll Michael Joseph · CIK 0001912097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,547 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2023. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:59 UTC |
Montecalvo Antonio S.VP Health Policy & Contracting
|
GrantStock Option (Right to Buy) · Derivative | 34,112 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001062993-22-004804 · form4.xml · derivative · entry 3 Montecalvo Antonio S. · CIK 0001759261 · VP Health Policy & Contracting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,112 Underlying: Class A Common Stock · 34,112 shares Expires 2032-02-15 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:59 UTC |
Montecalvo Antonio S.VP Health Policy & Contracting
|
GrantClass A Common Stock | 14,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004804 · form4.xml · nonDerivative · entry 1 Montecalvo Antonio S. · CIK 0001759261 · VP Health Policy & Contracting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,939 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 19:01 UTC |
Leibowitz Arthur SDirector
|
GrantClass A Common Stock | 20,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004806 · form4.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,854 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2023. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:53 UTC |
Freedman LoriVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 99,236 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001062993-22-004798 · form4.xml · derivative · entry 3 Freedman Lori · CIK 0001410291 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,236 Underlying: Class A Common Stock · 99,236 shares Expires 2032-02-15 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:53 UTC |
Freedman LoriVP and General Counsel
|
GrantClass A Common Stock | 41,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004798 · form4.xml · nonDerivative · entry 1 Freedman Lori · CIK 0001410291 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,594 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 19:02 UTC |
Giacomin Jon LDirector
|
GrantClass A Common Stock | 20,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004808 · form4.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,866 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2023. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 00:03 UTC |
Duraibabu PrathyushaDirector
|
GrantClass A Common Stock | 20,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004810 · form4.xml · nonDerivative · entry 1 Duraibabu Prathyusha · CIK 0001779092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,887 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2023. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:57 UTC |
Grow BrianChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 107,063 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001062993-22-004802 · form4.xml · derivative · entry 3 Grow Brian · CIK 0001759142 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,063 Underlying: Class A Common Stock · 107,063 shares Expires 2032-02-15 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:57 UTC |
Grow BrianChief Commercial Officer
|
GrantClass A Common Stock | 45,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004802 · form4.xml · nonDerivative · entry 1 Grow Brian · CIK 0001759142 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,715 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:55 UTC |
Bilbo PatrickChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,522 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001062993-22-004800 · form4.xml · derivative · entry 3 Bilbo Patrick · CIK 0001759203 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,522 Underlying: Class A Common Stock · 125,522 shares Expires 2032-02-15 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:55 UTC |
Bilbo PatrickChief Operating Officer
|
GrantClass A Common Stock | 52,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004800 · form4.xml · nonDerivative · entry 1 Bilbo Patrick · CIK 0001759203 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,596 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:51 UTC |
Francisco DavidChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 95,692 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001062993-22-004796 · form4.xml · derivative · entry 4 Francisco David · CIK 0001846282 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,692 Underlying: Class A Common Stock · 95,692 shares Expires 2032-02-15 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:51 UTC |
Francisco DavidChief Financial Officer
|
Tax withholdingClass A Common Stock | 1,876 | $8.03 | $15,064.28 |
DisclosureSEC source: 0001062993-22-004796 · form4.xml · nonDerivative · entry 2 Francisco David · CIK 0001846282 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,833 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:51 UTC |
Francisco DavidChief Financial Officer
|
GrantClass A Common Stock | 40,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004796 · form4.xml · nonDerivative · entry 1 Francisco David · CIK 0001846282 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,709 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:50 UTC |
Gillheeney Gary S.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 664,532 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001062993-22-004794 · form4.xml · derivative · entry 3 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 664,532 Underlying: Class A Common Stock · 664,532 shares Expires 2032-02-15 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:50 UTC |
Gillheeney Gary S.Director · President and CEO
|
GrantClass A Common Stock | 280,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004794 · form4.xml · nonDerivative · entry 1 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,116 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:26 UTC |
NUSSDORF GLENN HDirector · 10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
GiftClass A Common Stock | 7,392,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013660 · form4.xml · nonDerivative · entry 4 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:26 UTC |
NUSSDORF GLENN HDirector · 10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
GiftClass A Common Stock | 7,392,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013660 · form4.xml · nonDerivative · entry 3 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:26 UTC |
NUSSDORF GLENN HDirector · 10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
GiftClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013660 · form4.xml · nonDerivative · entry 2 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:26 UTC |
NUSSDORF GLENN HDirector · 10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
GiftClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013660 · form4.xml · nonDerivative · entry 1 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Albert Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC |
RED Holdings, LLC10% owner
Erani Dennis10% owner
|
GiftClass A Common Stock | 7,392,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 4 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC |
RED Holdings, LLC10% owner
Erani Dennis10% owner
|
GiftClass A Common Stock | 7,392,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 3 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC |
RED Holdings, LLC10% owner
Erani Dennis10% owner
|
GiftClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 2 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC |
RED Holdings, LLC10% owner
Erani Dennis10% owner
|
GiftClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 1 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Albert Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 20:55 UTC |
NUSSDORF GLENN HDirector · 10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
GiftClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013188 · form4.xml · nonDerivative · entry 2 Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 20:55 UTC |
NUSSDORF GLENN HDirector · 10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
GiftClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013188 · form4.xml · nonDerivative · entry 1 Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dennis Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:00 UTC |
Erani Dennis10% owner
|
GiftClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013189 · form4.xml · nonDerivative · entry 2 Erani Dennis · CIK 0001760685 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:00 UTC |
Erani Dennis10% owner
|
GiftClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013189 · form4.xml · nonDerivative · entry 1 Erani Dennis · CIK 0001760685 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dennis Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 18:47 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 500 | $9.65 | $4,825.00 |
DisclosureSEC source: 0001062993-21-012871 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,382 Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 17:48 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 800 | $9.35 | $7,480.00 |
DisclosureSEC source: 0001062993-21-012263 · form4.xml · nonDerivative · entry 3 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,882 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:48 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 800 | $9.55 | $7,640.00 |
DisclosureSEC source: 0001062993-21-012263 · form4.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,082 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:48 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $9.75 | $9,750.00 |
DisclosureSEC source: 0001062993-21-012263 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,282 Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 18:17 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $9.75 | $9,750.00 |
DisclosureSEC source: 0001062993-21-011910 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,282 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 20:15 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $9.75 | $9,750.00 |
DisclosureSEC source: 0001062993-21-011825 · form4.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,282 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 20:15 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $9.82 | $9,820.00 |
DisclosureSEC source: 0001062993-21-011825 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,282 Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 00:15 UTC |
Duraibabu PrathyushaDirector
|
GrantClass A Common Stock | 11,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-011496 · form4.xml · nonDerivative · entry 1 Duraibabu Prathyusha · CIK 0001779092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,340 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over three years beginning November 19, 2021. Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 20:39 UTC |
NUSSDORF GLENN HDirector · 10% owner
Erani Dennis10% owner
Ades Alan A.Director · 10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
PurchaseClass A Common Stock | 25,000 | $9.93 | $248,250.00 |
DisclosureSEC source: 0001062993-21-011406 · form4.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: The reported securities were purchased and held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $9.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| November 18, 2021 Filed Nov 23, 2021 01:39 UTC | PurchaseClass A Common Stock | 25,000 | $9.93 | $248,250.00 |
DisclosureSEC source: 0001062993-21-011407 · form4.xml · nonDerivative · entry 1 GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: The reported securities were purchased and held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $9.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
|
| November 17, 2021 Filed Nov 19, 2021 17:03 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $10.87 | $10,870.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 4 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,282 Read SEC document |
| November 15, 2021 Filed Nov 19, 2021 17:03 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $11.08 | $11,080.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 3 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,282 Read SEC document |
| November 12, 2021 Filed Nov 19, 2021 17:03 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 1,000 | $11.00 | $11,000.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,282 Read SEC document |
| November 12, 2021 Filed Nov 19, 2021 17:03 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 2,000 | $11.30 | $22,600.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,282 Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 23:01 UTC |
Bilbo PatrickChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,450 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001661181-21-000068 · edgar.xml · derivative · entry 2 Bilbo Patrick · CIK 0001759203 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,450 shares Expires 2021-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to this option are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.